Smoking Cessation and Nicotine De-Addiction Products Market Expected to Reach $54.7 Billion by 2031

Smoking Cessation and Nicotine De-Addiction Products Market size was valued at $20 billion in 2021, and is estimated to reach $54.7 billion by 2031, growing at a CAGR of 10.6% from 2022 to 2031. Smoking cessation refers to the act of quitting smoking. Nicotine, an alkaloid, makes people dependent on cigarettes and other smoking products. There are more than 7000 dangerous chemicals found in tobacco smoking that cause or exacerbate pre-existing illnesses such as diabetes, weakened immunity, respiratory illnesses, lungs cancer, cardiovascular issues, cataract, macular degeneration, eyesight loss, tooth or gum diseases, and impotence or infertility.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
British American Tobacco Inc., 22nd Century group Inc., Cipla Ltd., Dr. Reddy's Laboratories Ltd, GlaxoSmithKline PLC (Haleon), Imperial Brands Plc. (Fontem Ventures), Johnson and Johnson

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/469

𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗦𝗰𝗲𝗻𝗮𝗿𝗶𝗼:
In addition, every business has been impacted by the unmatched worldwide public health crisis known as COVID-19, and the long-term impacts are expected to have an influence on industry growth during the forecast period. Several changes in consumer demand and behavior, buying habits, supply chain redirection, and significant government initiatives have been seen around the globe. The COVID-19 pandemic has changed the patterns of smoking, other substance uses and other health-related behaviors of the smokers. Smokers in several nations have increased their tobacco consumption since the pandemic. On the other hand, there has also been a surge in interest in stopping, quit attempts, and successful cessation rates, which further caused prevalence of factors affecting growth of the smoking cessation and nicotine de-addiction products market size.

𝐁𝐮𝐲 𝐍𝐨𝐰 https://www.alliedmarketresearch.com/checkout-final/59c46b397e7078adc26323874216781c

Depending on distribution channel, the market is divided into hospital pharmacies, online providers, and drug stores and retail pharmacies. The drug stores and retail pharmacies segment dominated the market in 2021, and the online providers segment is expected to grow at the fastest CAGR, during the forecast period, owing to rise in digitalization, ease of purchase, faster delivery of products and accessibility of smartphones.

North America accounted for majority of the global smoking cessation and nicotine de-addiction products market share in 2021. On the other hand, Asia-Pacific is anticipated to dominate the smoking cessation and nicotine de-addiction products industry during the forecast period. This is attributed to increase in awareness regarding harmful effects of smoking that has forced many people in the region to quit smoking, which, in turn, propels the smoking cessation and nicotine de-addiction market. However, Asia-Pacific is anticipated to witness notable growth, owing to large prevalence of tobacco users in this region and rising rate of users to quit tobacco and smoking.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/469

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

By product type, in smoking cessation marketthe, e-cigarettes segment was the highest contributor to the market in 2021.

By form, the gum segment was the highest contributor to the smoking cessation and nicotine de-addiction products market analysis in 2021.

Depending on distribution channel, the drug stores and retail pharmacies segment was highest contributor in 2021, and the online providers segment is expected to grow at the highest CAGR during the forecast period.

Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

𝐎𝐮𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐘𝐨𝐮 𝐀𝐧𝐬𝐰𝐞𝐫 𝐭𝐨 𝐁𝐞𝐥𝐨𝐰 𝐌𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.